Leading intellectual property firm Stearne, Kessler, Goldstein & Fox announced the appointment of six of its lawyers to director, creating its largest directorship in the law firm’s history.
According to reports, among the six lawyers includes Dennies Varughese, a director at the firm’s litigation group with experience in antitrust and IP matters. He specializes in pharmaceutical and biotech patent litigation, and has experience advising clients in antitrust matters regarding pharmaceutical patent settlements.
The additional five lawyers include Richard D. Coller III, Nirav N. Desai, Jeremiah B. Frueauf, Jonathan M. Stranis, and Jonathan Tuminaro.
The law firm was founded in Washington, D.C. in 1978.
Full Content: IT Business Net
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Nominates Olivia Trusty for FCC Commissioner Role Ahead of Inauguration
Jan 16, 2025 by
CPI
Lawyers Claim eXp’s Settlement Tactics Hurt Antitrust Case Potential
Jan 16, 2025 by
CPI
Amex GBT Pushes Back Against DOJ Lawsuit Over CWT Acquisition
Jan 16, 2025 by
CPI
Belgium Opens Antitrust Probe into AB InBev’s Market Practices
Jan 16, 2025 by
CPI
Tech Groups Sue CFPB Over New Rule on Digital Wallet Oversight
Jan 16, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand